Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2012
/
Article
/
Tab 2
/
Clinical Study
RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution
Table 2
Schedules preconsolidation.
Treatment preconsolidation
Number of patients
%
R alone
6
27.3
R-CHOP
13
59.1
R-EPOCH
1
4.5
R-COP
2
9.1
Total
22
100
R: Rituximab 375 mg/m
2
.